Cargando…

A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression

Detalles Bibliográficos
Autores principales:	Su, Ganglin, Yao, Lin, Han, Xiaohong, Liao, Xinhui, Chen, Jieqing, Yin, Tao, Dong, Ying, Li, Yanfeng, Hu, Kun, Xiao, Junwen, Liu, Yuchen, Huang, Weiren, Mei, Hongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882238/ https://www.ncbi.nlm.nih.gov/pubmed/35220684 http://dx.doi.org/10.1002/ctm2.734

Ejemplares similares

CRISPR-Cas13-Mediated Knockdown of lncRNA-GACAT3 Inhibited Cell Proliferation and Motility, and Induced Apoptosis by Increasing p21, Bax, and E-Cadherin Expression in Bladder Cancer
por: Zhang, Zhongfu, et al.
Publicado: (2021)

YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Su, Ganglin, et al.
Publicado: (2021)

AB111. Synthesizing an AND gate genetic circuit for identification of bladder cancer cells based on CRISPR-Cas9
por: Liu, Yuchen, et al.
Publicado: (2014)

Targeted Methylation of the LncRNA NEAT1 Suppresses Malignancy of Renal Cell Carcinoma
por: Chen, Jieqing, et al.
Publicado: (2021)

Reprogrammable CRISPR/dCas9-based recruitment of DNMT1 for site-specific DNA demethylation and gene regulation
por: Lu, Anrui, et al.
Publicado: (2019)

Regulation of the CRISPR-Cas12a system by methylation and demethylation of guide RNA
por: Hu, Zhian, et al.
Publicado: (2023)

Improving transgene expression and CRISPR‐Cas9 efficiency with molecular engineering‐based molecules
por: Zhan, Hengji, et al.
Publicado: (2020)

Recent development on synthetic biological devices treating bladder cancer
por: Chen, Zhicong, et al.
Publicado: (2016)

Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation
por: Dong, Ying, et al.
Publicado: (2023)

Interfering with retrotransposition by two types of CRISPR effectors: Cas12a and Cas13a
por: Zhang, Niubing, et al.
Publicado: (2020)

Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer
por: He, Anbang, et al.
Publicado: (2016)

Targeting cellular mRNAs translation by CRISPR-Cas9
por: Liu, Yuchen, et al.
Publicado: (2016)

Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme
por: Zhan, Yonghao, et al.
Publicado: (2023)

Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro
por: Zhuang, Chengle, et al.
Publicado: (2021)

Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing
por: Hanzawa, Nozomi, et al.
Publicado: (2020)

Recent Advances in CRISPR-Cas Technologies for Synthetic Biology
por: Jeong, Song Hee, et al.
Publicado: (2023)

Synthetic CRISPR/dCas9-KRAB system driven by specific PSA promoter suppresses malignant biological behavior of prostate cancer cells through negative feedback inhibition of PSA expression
por: Yang, Yi, et al.
Publicado: (2023)

Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing
por: Zhang, Xin, et al.
Publicado: (2023)

CRISPR/Cas13d-Mediated Microbial RNA Knockdown
por: Zhang, Kun, et al.
Publicado: (2020)

CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter
por: Choudhury, Samrat Roy, et al.
Publicado: (2016)

CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer
por: Tejedor, Juan Ramón, et al.
Publicado: (2023)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria
por: Dong, Chen, et al.
Publicado: (2018)

CRISPR-Cas13a Inhibits HIV-1 Infection
por: Yin, Lijuan, et al.
Publicado: (2020)

CaSilico: A versatile CRISPR package for in silico CRISPR RNA designing for Cas12, Cas13, and Cas14
por: Asadbeigi, Adnan, et al.
Publicado: (2022)

Diagnostics of Infections Produced by the Plant Viruses TMV, TEV, and PVX with CRISPR-Cas12 and CRISPR-Cas13
por: Marqués, María-Carmen, et al.
Publicado: (2022)

Amplification-free RNA detection with CRISPR–Cas13
por: Shinoda, Hajime, et al.
Publicado: (2021)

Metagenomic discovery of novel CRISPR-Cas13 systems
por: Hu, Yanping, et al.
Publicado: (2022)

A CRISPR-based approach for targeted DNA demethylation
por: Xu, Xingxing, et al.
Publicado: (2016)

A Synthetic Light-switchable System based on CRISPR Cas13a Regulates the Expression of LncRNA MALAT1 and Affects the Malignant Phenotype of Bladder Cancer Cells
por: Qi, Fuming, et al.
Publicado: (2019)

Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B
por: Yang, Jiangeng, et al.
Publicado: (2017)

Implementation of the CRISPR-Cas13a system in fission yeast and its repurposing for precise RNA editing
por: Jing, Xinyun, et al.
Publicado: (2018)

Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer
por: Ding, Mengting, et al.
Publicado: (2018)

AB127. Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cell
por: Liu, Yuchen, et al.
Publicado: (2016)

Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9
por: Sapozhnikov, Daniel M., et al.
Publicado: (2021)

Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein
por: Li, Jiexin, et al.
Publicado: (2020)

A revolutionary tool: CRISPR technology plays an important role in construction of intelligentized gene circuits
por: Zhou, Qun, et al.
Publicado: (2018)

Targeted gene silencing in the nervous system with CRISPR-Cas13
por: Powell, Jackson E., et al.
Publicado: (2022)

Applications of CRISPR/Cas13-Based RNA Editing in Plants
por: Kavuri, Naga Rajitha, et al.
Publicado: (2022)

Highly multiplexed mRNA quantitation with CRISPR-Cas13
por: Kang, Brian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6nodqc9npiubld2n9j5s8locv1